| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |